Rubin LJ, Nicod P., Hillis D., et al. Treatment of primary pulmonary hypertension with nifedipine . Ann Intern Med1983;99:433.
2.
Rich S., Ganz R., Levy PSComparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension. Am J Cardiol1983;51:1104.
3.
Young TE, Lundquist LJ, Chesler E., et al. Comparative effect of nifedipine, verapamil and diltiazem on experimental pulmonary hypertension. Am J Cardiol1983;51:195.
4.
Rubis LJ, Stephenson LW, Johnston MR, et al. Comparison of effects of prostaglandin E1 and nitroprusside on pulmonary vascular resistance in children after open-heart surgery. Ann Thorac Surg1981 ;32: 563.
5.
Jones OD, Shore DF, Rigby ML, et al. The use of tolazoline hydrochloride as a pulmonary vasodilator in potentially fatal episodes of pulmonary vasoconstriction after cardiac surgery in children. Circulation1981;6411:134.
6.
Stahlman MTClinical description of bronchopulmonary dysplasia. J Pediatr1979;95:829.
7.
Brent B., Berger H., Mahler D., et al. Acute effects of hydralazine on the pulmonary circulation and right ventricular function in chronic lung disease and pulmonary hypertension (Abstract). Clin Res1982;30: 4A.
8.
Porter CJ, Gillette PC, Garson A., et al. Effects of verapamil on supraventricular tachycardia in children . Am J Cardiol1981;48:487.
9.
Spicer RL, Rocchini AP, Crowley DC, et al. Hemodynamic effects of verapamil in children and adolescents with hypertrophic cardiomyopathy. Circulation1983;67:413.
10.
Millard RW, Lathrop DA, Grupp S., et al. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms. Am J Cardiol1982;49: 499.
11.
Mitchell B. , Schroder JS, Mason JWComparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: a review. Am J Cardiol1982;49:629.
